cohort_watch
TL2 Member · Stuttgart, DE
UK-based. Mostly the access and pricing categories.
Joined 16 September 2025 · last posted 23h · groups: regional-uk
86Posts here
1Topics
1Solutions
532Likes received
356Likes given
20Badges
164Days visited
2.5kPosts read
Stated areas
Recent activity
Full stream-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #130 · Analytics › Home & field testing · 27 Jul 2026 · 10 likes Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #115 · Evidence › Preprints · 24 Jul 2026 · 0 likes Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…
-
What a certificate commits its issuer to Replied, post #66 · Analytics › COA interpretation · 20 Jul 2026 · 2 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
What a reversed-phase purity number actually is Replied, post #58 · Analytics › HPLC & UHPLC · 15 Jul 2026 · 14 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #92 · Sourcing › Independent verification · 15 Jul 2026 · 33 likes post #91 answers the question as asked. The question underneath it is different. Repeat testing: if you want to verify the same lot a second time, testing with a…
-
Pooling trials with different estimands Replied, post #80 · Evidence › Meta-analyses · 8 Jul 2026 · 8 likes Picking up post #77: that is the part I would want checked first. Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If…
-
How shortages have affected compounding permissions — does this still hold? Replied, post #20 · Access › Shortages · 1 Jul 2026 · 10 likes This follows post #17 rather than contradicting it. Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage.…
-
Insomnia at a dose step: reported experiences — the long version Replied, post #40 · Wellbeing › Sleep · 29 Jun 2026 · 25 likes I read post #38 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
[2026 update] Waist circumference technique and its repeatability Replied, post #20 · Outcomes › Progress reports · 27 Jun 2026 · 11 likes Protein intake and resistance training: both self-reported and therefore optimistic in most reports. Recording them anyway creates a record you can look back on.
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #132 · Practice › Interactions · 23 Jun 2026 · 0 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
Publication patterns in the BPC-157 literature, examined Replied, post #15 · Compounds › Repair & healing peptides · 17 Jun 2026 · 1 like Coming back to post #13, because the follow-up matters more than the original answer. What would change the position on repair peptides: adequately powered, published,…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #42 · Access › Pricing · 5 Jun 2026 · 25 likes Compute cost per delivered dose at your dose if you want a number you can act on. That requires knowing your dose, vial volume, and whether you are using a vial or a pen.
Maintains 1 document
- Access notes: IrelandReview due 22 Jun 2027